Opyl Ltd

AU:OPL Australia Health Information Services
Market Cap
$4.22 Million
AU$6.81 Million AUD
Market Cap Rank
#35479 Global
#1334 in Australia
Share Price
AU$0.02
Change (1 day)
+0.00%
52-Week Range
AU$0.02 - AU$0.03
All Time High
AU$13.50
About

Pathkey.AI Ltd engages in the development of digital tools that enhance healthcare experience for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs for pharmaceuticals, medical devices, alternative therapies, and novel conditions. It also provides TrialGen, an AI-powered tool strea… Read more

Opyl Ltd (OPL) - Net Assets

Latest net assets as of December 2024: AU$-310.99K AUD

Based on the latest financial reports, Opyl Ltd (OPL) has net assets worth AU$-310.99K AUD as of December 2024.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$384.82K) and total liabilities (AU$695.82K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets AU$-310.99K
% of Total Assets -80.81%
Annual Growth Rate N/A
5-Year Change -112.54%
10-Year Change -106.8%
Growth Volatility 200.08

Opyl Ltd - Net Assets Trend (1996–2024)

This chart illustrates how Opyl Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Opyl Ltd (1996–2024)

The table below shows the annual net assets of Opyl Ltd from 1996 to 2024.

Year Net Assets Change
2024-06-30 AU$-90.16K +77.66%
2023-06-30 AU$-403.59K -251.15%
2022-06-30 AU$267.01K -87.79%
2021-06-30 AU$2.19 Million +204.18%
2020-06-30 AU$719.18K +278.54%
2019-06-30 AU$-402.81K -128.89%
2018-06-30 AU$1.39 Million +503.97%
2017-06-30 AU$230.83K -89.60%
2016-06-30 AU$2.22 Million +67.38%
2015-06-30 AU$1.33 Million -77.05%
2014-06-30 AU$5.77 Million -30.54%
2013-06-30 AU$8.31 Million -17.87%
2012-06-30 AU$10.12 Million -28.55%
2011-06-30 AU$14.17 Million +739.22%
2010-06-30 AU$1.69 Million +141.80%
2009-06-30 AU$-4.04 Million -105.82%
2008-06-30 AU$69.38 Million +16.39%
2007-06-30 AU$59.61 Million +14.34%
2006-06-30 AU$52.13 Million +288.73%
2005-06-30 AU$13.41 Million -16.65%
2004-06-30 AU$16.09 Million +53.66%
2003-06-30 AU$10.47 Million +6.32%
2002-06-30 AU$9.85 Million +10.74%
2001-06-30 AU$8.89 Million -5.54%
2000-06-30 AU$9.41 Million +46.97%
1999-06-30 AU$6.41 Million -0.18%
1998-06-30 AU$6.42 Million +3.35%
1997-06-30 AU$6.21 Million +0.92%
1996-06-30 AU$6.15 Million --

Equity Component Analysis

This analysis shows how different components contribute to Opyl Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 2108181900.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2024)

Component Amount Percentage
Common Stock AU$22.50 Million %
Other Comprehensive Income AU$1.14 Million %
Total Equity AU$-90.16K 100.00%

Opyl Ltd Competitors by Market Cap

The table below lists competitors of Opyl Ltd ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Opyl Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from -403,586 to -90,160, a change of 313,426.
  • Net loss of 3,130,000 reduced equity.
  • Share repurchases of 189,166 reduced equity.
  • New share issuances of 2,039,358 increased equity.
  • Other comprehensive income increased equity by 491,578.
  • Other factors increased equity by 1,101,656.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income AU$-3.13 Million -3471.61%
Share Repurchases AU$189.17K -209.81%
Share Issuances AU$2.04 Million +2261.93%
Other Comprehensive Income AU$491.58K +545.23%
Other Changes AU$1.10 Million +1221.89%
Total Change AU$- %

Book Value vs Market Value Analysis

This analysis compares Opyl Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1996-06-30 AU$1269.70 AU$0.02 x
1997-06-30 AU$1254.66 AU$0.02 x
1998-06-30 AU$1064.40 AU$0.02 x
1999-06-30 AU$999.99 AU$0.02 x
2000-06-30 AU$690.17 AU$0.02 x
2001-06-30 AU$624.23 AU$0.02 x
2002-06-30 AU$585.52 AU$0.02 x
2003-06-30 AU$525.18 AU$0.02 x
2004-06-30 AU$531.75 AU$0.02 x
2005-06-30 AU$25398.18 AU$0.02 x
2006-06-30 AU$681.04 AU$0.02 x
2007-06-30 AU$226.28 AU$0.02 x
2008-06-30 AU$19075.31 AU$0.02 x
2009-06-30 AU$-7.83 AU$0.02 x
2010-06-30 AU$0.12 AU$0.02 x
2011-06-30 AU$0.73 AU$0.02 x
2012-06-30 AU$0.28 AU$0.02 x
2013-06-30 AU$21.04 AU$0.02 x
2014-06-30 AU$14.51 AU$0.02 x
2015-06-30 AU$0.04 AU$0.02 x
2016-06-30 AU$0.92 AU$0.02 x
2017-06-30 AU$0.06 AU$0.02 x
2018-06-30 AU$0.15 AU$0.02 x
2019-06-30 AU$-0.02 AU$0.02 x
2020-06-30 AU$0.05 AU$0.02 x
2021-06-30 AU$0.05 AU$0.02 x
2022-06-30 AU$0.00 AU$0.02 x
2023-06-30 AU$0.00 AU$0.02 x
2024-06-30 AU$0.00 AU$0.02 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Opyl Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -787.15%
  • • Asset Turnover: 0.97x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-113.24%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1996 -41.75% 0.00% 0.00x 1.10x AU$-3.18 Million
1997 -12.87% 0.00% 0.00x 1.03x AU$-1.42 Million
1998 -5.98% 0.00% 0.00x 1.01x AU$-1.03 Million
1999 -9.71% 0.00% 0.00x 1.11x AU$-1.26 Million
2000 -5.41% 0.00% 0.00x 1.03x AU$-1.45 Million
2001 -7.66% 0.00% 0.00x 1.08x AU$-1.57 Million
2002 -5.09% 0.00% 0.00x 1.05x AU$-1.49 Million
2003 -7.52% 0.00% 0.00x 1.03x AU$-1.83 Million
2004 -6.20% 0.00% 0.00x 1.16x AU$-2.61 Million
2005 -51.08% 0.00% 0.00x 1.10x AU$-8.19 Million
2006 -4.57% 0.00% 0.00x 1.03x AU$-7.59 Million
2007 -2.53% -603.60% 0.00x 1.35x AU$-7.47 Million
2008 -6.16% 0.00% 0.00x 1.35x AU$-11.21 Million
2009 0.00% 0.00% 0.00x 0.00x AU$-73.27 Million
2010 188.49% 0.00% 0.00x 1.01x AU$3.01 Million
2011 -2.27% 0.00% 0.00x 1.11x AU$-1.74 Million
2012 -42.86% 0.00% 0.00x 1.02x AU$-5.35 Million
2013 -24.29% 0.00% 0.00x 1.04x AU$-2.85 Million
2014 -46.17% -552.75% 0.08x 1.03x AU$-3.24 Million
2015 -337.77% -7054.39% 0.05x 1.02x AU$-4.61 Million
2016 -274.19% -10855.33% 0.02x 1.10x AU$-6.30 Million
2017 -1398.45% -1470.92% 0.35x 2.72x AU$-3.25 Million
2018 -217.77% -734.11% 0.20x 1.46x AU$-3.18 Million
2019 0.00% -334.94% 2.81x 0.00x AU$-3.06 Million
2020 -128.76% -149.17% 0.66x 1.30x AU$-997.92K
2021 -52.25% -148.88% 0.31x 1.14x AU$-1.36 Million
2022 -781.25% -231.16% 0.92x 3.67x AU$-2.11 Million
2023 0.00% -279.33% 0.87x 0.00x AU$-1.69 Million
2024 0.00% -787.15% 0.97x 0.00x AU$-3.12 Million

Industry Comparison

This section compares Opyl Ltd's net assets metrics with peer companies in the Health Information Services industry.

Industry Context

  • Industry: Health Information Services
  • Average net assets among peers: $19,142,795
  • Average return on equity (ROE) among peers: -52.12%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Opyl Ltd (OPL) AU$-310.99K -41.75% N/A $1.28 Million
Adheris Health Limited (AHE) $51.58 Million 1.54% 0.92x $119.94
Alcidion Group Ltd (ALC) $6.57 Million -38.71% 0.23x $60.88 Million
ARTRYA Ltd (AYA) $40.64 Million -42.21% 0.08x $148.36 Million
Blinklab Ltd (BB1) $6.48 Million -27.04% 0.06x $39.10 Million
Beamtree Holdings Ltd (BMT) $29.22 Million 1.31% 0.10x $18.03 Million
Cogstate Ltd (CGS) $29.02 Million 24.18% 1.36x $124.86 Million
Careteq Ltd (CTQ) $3.55 Million -121.85% 1.13x $621.63K
Doctor Care Anywhere Group Plc (DOC) $12.29 Million -179.31% 0.79x $21.76 Million
Echoiq Ltd (EIQ) $6.77 Million -79.92% 0.22x $168.60 Million
Emyria Ltd (EMD) $5.31 Million -59.24% 0.25x $11.75 Million